Amanda Colbert

A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non‐Hodgkin's lymphoma

C. Flowers, S. Lonial, J. Kaufman, 2015, British journal of haematology.

Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial.

C. Flowers, Zhengjia Chen, E. Waller, 2022, Clinical lymphoma, myeloma & leukemia.

Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma.

C. Flowers, S. Lonial, E. Waller, 2015, Clinical lymphoma, myeloma & leukemia.

A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non‐Hodgkin's lymphoma

C. Flowers, S. Lonial, J. Kaufman, 2015, British journal of haematology.